Breaking News, Collaborations & Alliances

Horizon, Transgenomic in Genetic Diagnostic Alliance

To transition assays to Horizon’s Quantitative Molecular Reference Standards

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Horizon and Transgenomic, Inc. have entered into a collaboration to develop improved genetic diagnostic tests using Horizon’s Quantitative Molecular Reference Standards for all of its existing and future assays using plasmid-derived controls.   Horizon will provide its renewable, genetically defined Quantitative Molecular Reference Standards in both gDNA (genomic DNA) and FFPE (formalin fixed paraffin embedded) format. The Quantitative Molecular Reference Standards will be used for Transgenomic’...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters